Uptake of FITC-chitosan nanoparticles by A549 cells

Pharmaceutical Research

Volumn 19, Issue 10, 2002, Pages 1488-1494

  Huang, Min ^a   Ma, Zengshuan ^a   Khor, Eugene ^a   Lim, Lee Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

A549 cells; Chitosan; FITC; Nanoparticles; Uptake

Indexed keywords

CHITOSAN; CHLORPROMAZINE; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE;

ADSORPTION; ARTICLE; CELL LINE; CONJUGATION; CONTROLLED STUDY; ENDOCYTOSIS; FLUOROMETRY; GELATION; HUMAN; HUMAN CELL; HYPEROSMOLARITY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; TEMPERATURE DEPENDENCE;

CHITIN; CHITOSAN; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; NANOTECHNOLOGY; TUMOR CELLS, CULTURED;

EID: 0036804673     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020404615898     Document Type: Article

References (30)

1. N. G. M. Schipper, S. Olsson, J. A. Hoogstraate, A. G. deBoer, K. M. Vårum, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 14:923-929 (1997).
2. N. G. M. Schipper, K. M. Vårum, P. Stenberg, G. Ocklind, H. Lennernäs, and P. Artursson. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8:335-343 (1999).
3. A. F. Kotzé H. L. Lueßen, A. G. deBoer, J. C. Verhoef, and H. E. Junginger. Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments. Eur. J. Pharm. Sci. 7:145-151 (1998).
4. H.-Q. Mao, K. Roy, V. L. Troung-Le, and K. A. Janes, K. Y. Lin, Y. Wang, J. T. August, and K. W. Leong. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J. Control. Release 70:399-421 (2001).
5. L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51:81-96 (2001).
6. K. A. Janes, M. P. Fresneau, A. Marazuela, A. Fabra, and M. J. Alonso. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 73:255-267 (2001).
7. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao, and T. Kissel. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50:147-160 (2000).
8. F. Delie. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34:221-223 (1998).
9. K. Suh, B. Jeong, F. Liu, and S. W. Kim. Cellular uptake study of biodegradable nanoparticles in muscular smooth cells. Pharm. Res. 12:1495-1498 (1998).
10. B. Q. Roula and M. A. Mansoor. Synthesis of a fluorescent chitosan derivative and its application for the study of chitosanmucin interactions. Carbohydr. Polym. 38:99-107 (1999).
11. O. Hiraku and M. Yoshiharu. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175-182 (1999).
12. W. Wang, S. Q. Bo, S. Q. Li, and W. Qin. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int. J. Biol. Macromol. 13:281-285 (1991).
13. S. C. Tan, E. Khor, T. K. Tan, and S. M. Wong. The degree of deacetylation of chitosan: Advocating the first derivative UV-spectrophotometry method of determination. Talanta 45:713-719 (1998).
14. P. Calvo, C. Remuñán-López, J. L. Vila-Jato, and M. J. Alonso. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polymer Sci. 63:125-132 (1997).
15. W. Lutz and R. Kumar. Hypertonic sucrose treatment enhances second messenger accumulation in vasopressin-sensitive cells. Am. J. Physiol. 264:F228-F233 (1993).
16. G. G. Pietra, L. Johns, W. Byrnes, and S. Villaschi. Inhibition of adsorptive endocytosis and transcytosis in pulmonary microvessels. Lab. Invest. 59:683-690 (1988).
17. R. Miñana, J. M. Duran, M. Tomas, J. Renau-Piqueras, and C. Guerri. Neural cell adhesion molecule is endocytosed via a clathrin-dependent pathway. Eur. J. Neurosci. 13:749-756 (2001).
18. I. H. Madshus, K. Sandvig, S. Olsnes, and B. V. Deurs. Effect of reduced endocytosis induced by hypotonic shock and potassium depletion on the infection of Hep 2 cells by picornaviruses. J. Cell Physiol. 131:14-22 (1987).
19. G. Daukas and S. H. Zigmond. Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J. Cell Biol. 101:1673-1679 (1985).
20. P. A. Orlandi and P. H. Fishman. Filipin-dependent inhibition of cholera toxin: Evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141:905-915 (1998).
21. C. M. Lehr. The transcytosis approach. In A.G. de Boer (ed.), Drug Absorption Enhancement-Concepts, Possibilities, Limitations and Trends, Harwood Academic, Switzerland, 1994, pp. 325-366.
22. B. J. Nichols and J. Lippincott-Schwartz, Endocytosis without clathrin coats. Trends Cell Biol. 11:406-412 (2001).
23. J. E. Schnitzer. Caveolae: From basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv. Drug Deliv. Rev 49:265-280 (2001).
24. L. H. Wang, K. G. Rothberg, and R. G. Anderson. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123:1107-1117 (1993).
25. C. Racine, M. Belanger, H. Hirabayashi, M. Boucher, J. Chakir, and J. Couet. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 255:580-586 (1999).
26. N. G. M. Schipper. K. M Vårum and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res. 13: 1686-1692 (1996).
27. L. Illum, N. F. Farraj, and S. S. Davis. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1186-1189 (1994).
28. N. Haffejee, J. Du Plessis, D. G. Muller, C. Schultz, A. F. Kotze, and C. Goosen. Intranasal toxicity of selected absorption enhancers. Pharmazie 56:882-888 (2001).
29. J. A. Swanson and C. Watts. Macropinocytosis. Trends Cell Biol. 5:424-428 (1995).
30. R. C. Stearns, J. D. Paulauskis, and J. J. Godleski. Endocytosis of ultrafine particles by A549 cells. Am. J. Respir. Cell Mol. Biol. 24:108-115 (2001).